Figure 1.

Combination of MV-MMCT and iPSC technologies for biomedical applications

(A) Process of conventional MMCT (PEG-MMCT) is shown at the top. The process of MV-MMCT is shown at the bottom. (B) Biomedical applications of the combination of MV-MMCT and iPSC technologies. The HAC-mediated gene and cell therapy model via MV-MMCT is shown at the top. Establishment of a versatile iPSC line carrying the basal-HAC capable of gene(s) loading is shown in the middle. Generation of disease model cells for aneuploidy syndrome by MV-MMCT is shown at the bottom.